Increased NF-κB activity in B cells and bone marrow-derived dentritic cells from NOD mice

European Journal of Immunology

Volumn 34, Issue 5, 2004, Pages 1395-1404

  Wheat, William ^a,c   Kupfer, Rene ^b   Gutches, Diane ^a   Rayat, Gina R ^a   Beilke, Joshua ^a   Scheinman, Robert I ^b   Wegmann, Dale R ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

B cell; Dentritic cell; NF B; NOD mouse; Type 1 diabetes

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; AUTOANTIGEN; INSULIN; MEMBRANE PROTEIN; PROTEIN TYROSINE PHOSPHATASE; PTPRN2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVITY; CELL ASSAY; CELL FUNCTION; CELL MANIPULATION; CELL NUCLEUS; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; GENE TRANSLOCATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; T LYMPHOCYTE; ANIMAL; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL NUCLEUS; DENDRITIC CELLS; INSULIN; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; NF-KAPPA B; PROTEIN-TYROSINE-PHOSPHATASE; T-LYMPHOCYTES;

EID: 2942746324     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324490     Document Type: Article

References (37)

1. Serreze, D. V., Leiter, E. H., Christianson, G. J., Greiner, D. and Roopenian, D. C., Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994. 43: 505-509.
2. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 1995. 181: 1145-1155.
3. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000. 12: 431-440.
4. Piganelli, J. D., Martin, T. and Haskins, K., Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 1998. 47: 1212-1218.
5. Alleva, D. G., Pavlovich, R. P., Grant, C., Kaser, S. B. and Beller, D. I., Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 2000. 49: 1106-1115.
6. Serreze, D. V., Gaedeke, J. W. and Leiter, E. H., Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 1993. 90: 9625-9629.
7. Fuchs, E. J. and Matzinger, P., B cells turn off virgin but not memory T cells. Science 1992. 258: 1156-1159.
8. Eynon, E. E. and Parker, D. C., Parameters of tolerance induction by antigen targeted to B lymphocytes. J. Immunol. 1993. 151: 2958-2964.
9. Greeley, S. A., Moore, D. J., Noorchashm, H., Noto, L. E., Rostami, S. Y., Schlachterman, A., Song, H. K., Koeberlein, B., Barker, C. F. and Naji, A., Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J. Immunol. 2001. 167: 4351-4357.
10. Chiu, P. P., Serreze, D. V. and Danska, J. S., Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes 2001. 50: 763-770.
11. Ghosh, S., May, M. J. and Kopp, E. B., NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998. 16: 225-260.
12. Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Kloting, I., Morcos, M., Hofmann, M., Tritschler, H., Weigle, B., Kasper, M., Smith, M., Perry, G., Schmidt, A. M., Stern, D. M., Haring, H. U., Schleicher, E. and Nawroth, P. P., Diabetes- associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001. 50: 2792-2808.
13. Baldwin, A. S., Jr., The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996. 14: 649-683.
14. Regnier, C. H., Song, H. Y., Gao, X., Goeddel, D. V., Cao, Z. and Rothe, M., Identification and characterization of an IkappaB kinase. Cell 1997. 90: 373-383.
15. + dendritic cells. Immunity 1998. 9: 839-847.
16. Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems, F., Haegeman, G. and Goldman, M., N-acetyl-l-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 1999. 162: 2569-2574.
17. Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F. and Siebenlist, U., Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997. 11: 3482-3496.
18. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y. and Beg, A. A., Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002. 16: 257-270.
19. Weih, F., Carrasco, D., Durham, S. K., Barton, D. S., Rizzo, C. A., Ryseck, R. P., Lira, S. A. and Bravo, R., Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell 1995. 80: 331-340.
20. Murphy, T. L., Cleveland, M. G., Kulesza, P, Magram, J. and Murphy, K. M., Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 1995. 15: 5258-5267.
21. Wegmann, D. R., Norbury-Glaser, M. and Daniel, D., Insulin- specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 1994. 24: 1853-1857.
22. Daniel, D., Gill, R. G., Schloot, N. and Wegmann, D., Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 1995. 25: 1056-1062.
23. Daniel, D. and Wegmann, D. R., Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA 1996. 93: 956-960.
24. Kelemen, K., Crawford, M. L., Gill, R. G., Hutton, J. C. and Wegmann, D., Cellular immune response to phogrin in the NOD mouse: cloned T cells cause destruction of islet transplants. Diabetes 1999. 48: 1529-1534.
25. Hayashi, T. and Faustman, D., NOD mice are defective in proteasome production and activation of NF-kappaB. Mol. Cell. Biol. 1999. 19: 8646-8659.
26. Kupfer, R. and Scheinman, R. I., Measurement of IKK activity in primary rat T cells: rapid activation and inactivation. J. Immunol. Methods 2002. 266: 155-164.
27. Weaver, D. J., Jr., Poligone, B., Bui, T., Abdel-Motal, U. M., Baldwin, A. S., Jr. and Tisch, R., Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase. J. Immunol. 2001. 167: 1461-1468.
28. Kanazawa, Y., Komeda, K., Sato, S., Mori, S., Akanuma, K. and Takaku, F., Non-obese-diabetic mice: immune mechanisms of pancreatic beta-cell destruction. Diabetologia 1984. 27 Suppl: 113-115.
29. Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino- Kurihara, H., Nakajima, H., Nonaka, K. and Tarui, S., Predominance of T lymphocytes in pancreatic islets and spleen of prediabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 1985. 60: 622-630.
30. Serreze, D. V., Chapman, H. D., Varnum, D. S., Hanson, M. S., Reifsnyder, P. C., Richard, S. D., Fleming, S. A., Leiter, E. H. and Shultz, L. D., B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J. Exp. Med. 1996. 184: 2049-2053.
31. Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H. and Tisch, R. M., B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 1998. 161: 3912-3918.
32. Noorchashm, H., Noorchashm, N., Kern, J., Rostami, S. Y., Barker, C. F. and Naji, A., B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997. 46: 941-946.
33. Noorchashm, H., Lieu, Y. K., Noorchashm, N., Rostami, S. Y., Greeley, S. A., Schlachterman, A., Song, H. K., Noto, L. E., Jevnikar, A. M., Barker, C. F. and Naji, A., I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J. Immunol. 1999. 163: 743-750.
34. Noorchashm, H., Moore, D. J., Noto, L. E., Noorchashm, N., Reed, A. J., Reed, A. L., Song, H. K., Mozaffari, R., Jevnikar, A. M., Barker, C. F. and Naji, A., Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J. Immunol. 2000. 165: 4685-4696.
35. Mamula, M. J., Lin, R. H., Janeway, C. A., Jr. and Hardin, J. A., Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. J. Immunol. 1992. 149: 789-795.
36. Shevach, E. M., Flow cytometry. In Coligan, J. E., Kruisbeek, A. M., Marguiles, D. H., Shevach, E. M. and Strober, W. (Eds.) Current Protocols in Immunology. John Wiley & Sons 1994, Section 5.3.6.
37. Wheat, W., Fitzsimmons, D., Lennox, H., Krautkramer, S. R., Gentile, L. N., McIntosh, L. P. and Hagman, J., The highly conserved beta-hairpin of the paired DNA-binding domain is required for assembly of Pax-Ets ternary complexes. Mol. Cell. Biol. 1999. 19: 2231-2241.